Compare ELME & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELME | BNR |
|---|---|---|
| Founded | 1960 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.5M | 169.9M |
| IPO Year | 1994 | 2019 |
| Metric | ELME | BNR |
|---|---|---|
| Price | $1.75 | $15.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 45.0K |
| Earning Date | 10-22-2026 | 11-19-2026 |
| Dividend Yield | ★ 838.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $206,360,000.00 | N/A |
| Revenue This Year | N/A | $101.46 |
| Revenue Next Year | $52.13 | $14.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.26 | $6.79 |
| 52 Week High | $17.68 | $41.72 |
| Indicator | ELME | BNR |
|---|---|---|
| Relative Strength Index (RSI) | 61.70 | 53.23 |
| Support Level | $1.62 | $8.91 |
| Resistance Level | $2.06 | $19.10 |
| Average True Range (ATR) | 0.02 | 1.76 |
| MACD | 0.00 | -0.29 |
| Stochastic Oscillator | 92.86 | 32.48 |
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. It derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Elme Communities' tenants are banking, consulting, law, and financial services firms. The company operates in a single reportable segment which includes the ownership, development, redevelopment and acquisition of apartment communities.
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.